A detailed history of Merit Financial Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 14,072 shares of GILD stock, worth $1.32 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,072
Previous 15,916 11.59%
Holding current value
$1.32 Million
Previous $1.09 Million 8.07%
% of portfolio
0.03%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$66.59 - $83.99 $122,791 - $154,877
-1,844 Reduced 11.59%
14,072 $1.18 Million
Q2 2024

Aug 13, 2024

SELL
$63.15 - $72.88 $182,187 - $210,258
-2,885 Reduced 15.34%
15,916 $1.09 Million
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $466,916 - $569,392
6,523 Added 53.13%
18,801 $1.38 Million
Q4 2023

Feb 06, 2024

SELL
$73.27 - $83.09 $512,450 - $581,131
-6,994 Reduced 36.29%
12,278 $994,000
Q3 2023

Nov 07, 2023

SELL
$73.94 - $80.67 $5,841 - $6,372
-79 Reduced 0.41%
19,272 $1.44 Million
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $402,092 - $458,643
5,290 Added 37.62%
19,351 $1.49 Million
Q1 2023

Apr 24, 2023

BUY
$77.31 - $88.08 $161,268 - $183,734
2,086 Added 17.42%
14,061 $1.17 Million
Q4 2022

Jan 13, 2023

BUY
$62.32 - $89.47 $194,064 - $278,609
3,114 Added 35.14%
11,975 $0
Q3 2022

Oct 31, 2022

SELL
$59.54 - $68.01 $381,532 - $435,808
-6,408 Reduced 41.97%
8,861 $547,000
Q2 2022

Aug 08, 2022

BUY
$57.72 - $65.01 $881,326 - $992,637
15,269 New
15,269 $944,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.